Cumberland Pharmaceuticals has joined the list of developers looking to raise money in an IPO. Cumberland filed SEC papers for an offering designed to raise $115 million. UBS Investment Bank and Jefferies & Co. are leading the deal's underwriting. The Nashville-based company says it may use some of the money for new acquisitions. Its strategy has been to acquire approved or late-stage therapies. Cumberland also runs a life sciences incubator.
- read Cumberland's release
- here's the report on the IPO from the Nashville Business Journal